Literature DB >> 19738165

Monitoring ovarian cancer: CA125 trial stirs controversy.

Radha Chitale.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19738165     DOI: 10.1093/jnci/djp316

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

Review 1.  Current and future applications of magnetic resonance imaging (MRI) to breast and ovarian cancer patient management.

Authors:  Jim Klostergaard; Kenia Parga; Raphael G Raptis
Journal:  P R Health Sci J       Date:  2010-09       Impact factor: 0.705

2.  The Role of Proteomics in the Diagnosis and Treatment of Women's Cancers: Current Trends in Technology and Future Opportunities.

Authors:  Eun-Kyoung Yim Breuer; Mandi M Murph
Journal:  Int J Proteomics       Date:  2011-01-01

3.  Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer.

Authors:  Katharine M Esselen; Angel M Cronin; Kristin Bixel; Michael A Bookman; Robert A Burger; David E Cohn; Mihaela Cristea; Jennifer J Griggs; Charles F Levenback; Gina Mantia-Smaldone; Larissa A Meyer; Ursula A Matulonis; Joyce C Niland; Charlotte Sun; David M O'Malley; Alexi A Wright
Journal:  JAMA Oncol       Date:  2016-11-01       Impact factor: 31.777

4.  Biomarkers, the molecular gaze and the transformation of cancer survivorship.

Authors:  Kirsten Bell
Journal:  Biosocieties       Date:  2013-06

5.  RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female Cancers.

Authors:  Wendell D Jones; Chad M Michener; Charles Biscotti; Iona Braicu; Jalid Sehouli; Mahrukh K Ganapathi; Ram N Ganapathi
Journal:  Cancers (Basel)       Date:  2020-03-07       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.